{"id":"W2765460113","doi":"10.1016/j.jval.2017.08.2973","title":"Secukinumab Shows Higher Symptomatic Improvement and Lower Cost Per Response vs. Adalimumab After One Year Treatment of Active Ankylosing Spondylitis: A Cost Per Responder Analysis from A Chilean Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Adalimumab; Secukinumab; Medicine; Ankylosing spondylitis; Internal medicine; Psoriatic arthritis; Tumor necrosis factor alpha; Arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002757166,0.0006239673,0.001365568,0.001278378,0.0002189879,0.00191409,0.0005528908,0.0007338669,0.0056661],"category_scores_gemma":[0.004574707,0.0002929639,0.003552406,0.001367684,0.0005006844,0.0009579289,0.0006410992,0.001187592,0.0002392905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003873826,"about_ca_system_score_gemma":0.001372328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01528639,"about_ca_topic_score_gemma":0.01018974,"domain_scores_codex":[0.9984601,0.001031179,0.00007163011,0.0001007303,0.0001631802,0.0001732666],"domain_scores_gemma":[0.9971922,0.001882352,0.000479905,0.0001341161,0.0001644788,0.0001469611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.135883,0.002777045,0.4773039,0.006296995,0.04047944,0.002572284,0.001092902,0.08151471,0.008221388,0.01365972,0.01044056,0.219758],"study_design_scores_gemma":[0.01141446,0.01144303,0.8834673,0.001441877,0.02179265,0.001687661,0.003041718,0.04145387,0.002299353,0.00667988,0.01502183,0.0002564662],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9728481,0.01638152,0.0008388716,0.003123188,0.00006115054,0.0001113819,0.002240232,0.00001770948,0.004377918],"genre_scores_gemma":[0.9950427,0.00202537,0.0003732488,0.0003076379,0.00003799131,0.00004312754,0.0009357384,0.00001295415,0.001221264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01528639,"threshold_uncertainty_score":0.03039479,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03133953096601857,"score_gpt":0.3190984669833122,"score_spread":0.2877589360172936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}